Cerebellar ataxia, areflexia, pes cavus, optic atrophy and sensorineural hearing impairment (CAPOS) is a rare clinically distinct syndrome caused by a single dominant missense mutation, c.2452G>A, p.Glu818Lys, in ATP1A3, encoding the neuron-specific alpha subunit of the Na+/K+-ATPase α3. Allelic mutations cause the neurological diseases rapid dystonia Parkinsonism and alternating hemiplegia of childhood, disorders which do not encompass hearing or visual impairment. We present detailed clinical phenotypic information in 18 genetically confirmed patients from 11 families (10 previously unreported) from Denmark, Sweden, UK and Germany indicating a specific type of hearing impairment-auditory neuropathy (AN). All patients were clinically suspected of CAPOS and had hearing problems. In this retrospective analysis of audiological data, we show for the first time that cochlear outer hair cell activity was preserved as shown by the presence of otoacoustic emissions and cochlear microphonic potentials, but the auditory brainstem responses were grossly abnormal, likely reflecting neural dyssynchrony. Poor speech perception was observed, especially in noise, which was beyond the hearing level obtained in the pure tone audiograms in several of the patients presented here. Molecular modelling and in vitro electrophysiological studies of the specific CAPOS mutation were performed. Heterologous expression studies of α3 with the p.Glu818Lys mutation affects sodium binding to, and release from, the sodium-specific site in the pump, the third ionbinding site. Molecular dynamics simulations confirm that the structure of the C-terminal region is affected. In conclusion, we demonstrate for the first time evidence for auditory neuropathy in CAPOS syndrome, which may reflect impaired propagation of electrical impulses along the spiral ganglion neurons. This has implications for diagnosis and patient management. Auditory neuropathy is difficult to treat with conventional hearing aids, but preliminary improvement in speech perception in some patients suggests that cochlear implantation may be effective in CAPOS patients.
Introduction
CAPOS syndrome (OMIM 601338) is a rare but highly distinctive cause of hearing impairment, first described in a mother and two children in 1996 (Nicolaides et al. 1996) ; seven further families and isolated cases (in total 22 patients) have been described subsequently (Demos et al. 2014; Rosewich et al. 2014; Heimer et al. 2015; Potic et al. 2015; Maas et al. 2016) . It is caused by one specific, dominant, missense mutation in the ATP1A3 gene, on chromosome 19q13.2 (Demos et al. 2014) , encoding the neuron-specific alpha subunit of the Na+/K+-ATPase α3, while other mutations in the same gene cause neurological syndromes without hearing impairment or optic atrophy, namely rapid dystonia and Parkinsonism (RDP) and alternating hemiplegia of childhood (AHC) (Dard et al. 2015; Sweney et al. 2015) . CAPOS is thus clinically and molecularly distinct. The clinical picture is remarkable, characterized by sudden onset of cerebellar ataxia precipitated by a febrile illness in childhood. Episodes are often recurrent and they can involve extended periods of reduced consciousness, hypotonia, ataxia and loss of the ability to walk, which may take weeks or months to regain. Months or years later, the patients experience progressive sensorineural hearing impairment, optic atrophy, loss of deep tendon reflexes, and in some subjects, pes cavus. Cognition and brain imaging are usually normal (Maas et al. 2016) . None of the previous reports have characterized the audiological phenotype to be an auditory neuropathy.
For all three allelic disorders, AHC, RDP and CAPOS, fever has been reported as a trigger, and several symptoms have been observed in all three groups, including ataxia, (asymmetric) dystonia, dysarthria, bradykinesia and abnormal ocular movements. For AHC, there are clear mutational hotspots with a majority of the patients having one of three residues affected, all in the transmembrane part of the protein at or close to the ion-binding residues. In contrast, the RDP-causing mutations map more broadly onto the pump structure (Clausen et al. 2017) . Effects on protein expression have been reported for RDP, but not AHC mutations (Heinzen et al. 2014) .
The Na, K-ATPase establishes the steep gradients of sodium and potassium across animal cell membranes that are important for numerous processes, not least in neurons, where the firing of action potentials depends directly on the flow of these ions. In grey matter, it is estimated that as much as 75% of the energy produced in the brain is spent by the Na, K-ATPase (Attwell and Laughlin 2001) . A Na, K-ATPase consists of three subunits, the catalytic α and two auxiliary subunits, β and FXYD, important for stability, trafficking and kinetic parameters (Geering 2005) . The α subunit has ten transmembrane helices that transport three Na + ions out of the cell and take up two K + ions at the expense of one ATP during each catalytic cycle (Fig. 1) .
There are several isoforms of each of the subunits; there are three types of α subunit in brain of which α1 is broadly expressed, α2 is mostly in glia cells, and α3 is in neurons (Clausen et al. 2017; Watts et al. 1991; Schuth et al. 2014 ). In the inner ear of rats, α3 was detected in the spiral ganglion neurons (SGNs) on hair cells, while α1 was detected in the hair cells themselves (Schuth et al. 2014) .
In the majority of cases, sensorineural hearing impairment is caused by defects of auditory transduction (conversion of sound energy into electrical activity) and active amplification of cochlear vibrations by the electromotile outer hair cells (OHCs) . Cochlear transduction and amplification can be directly reported by measuring sound emissions from the ear (otoacoustic emissions (Kemp 1978) or cochlear microphonics (the receptor potential generated by OHC). OAEs are absent when cochlear transduction and amplification fail, which makes them a useful screen for the majority of cases of congenital hearing impairment. In contrast, far less is known about hearing disorders affecting the auditory pathway beyond the OHCs, for example those affecting only inner hair cell (IHC) synapses, synaptic transmission to afferent spiral ganglion neurons (SGNs) or conduction of information by the auditory nerve to higher auditory centres (Rance and Starr 2015; Moser and Starr 2016) . This type of hearing impairment is termed auditory neuropathy (AN) or auditory synaptopathy if synaptic sound encoding is affected. It is characterized by normal OHC amplification and the presence of OAEs and/or cochlear microphonics, but abnormal auditory nerve function, as measured by auditory brain stem responses (ABRs) and/or compound action potential by electrocochleography (CAP) (Rance and Starr 2015; Santarelli et al. 2015) . ABRs require Fig. 1 Schematic of the catalytic cycle of the Na, K-ATPase. The forward reaction of the pump is clock-wise. The membrane is indicated by horizontal lines with the extracellular compartment denoted 'ex' and the cytoplasm denoted 'in'. In the so-called E1 state, the enzyme has high affinity for sodium, and in the E2 state it has high affinity for potassium. During the cycle, the enzyme acts as both substrate, kinase and phosphatase, and the phosphorylated states of the pump are denoted with a P (E1P and E2P). Starting in the top left corner, the pump has three Na + (blue spheres) occluded in the E1P state that are released extracellularly when the pump opens to the outside in the E2P state. The open pump will bind two K + (red spheres) and dephosporylate to the E2 state where the K + are occluded. Opening of the pump on the intracellular side and transition to the E1 state allows release of K + and binding of Na + . With phosphorylation of the pump, the Na + are then occluded in the E1P state. The P in the E1P and E2P states signifies that the pump is phosphorylated by the ATP that provides the energy for the transport. A full circle depends on intracellular Na + and ATP and extracellular K + . The grey square indicates that in the absence of extracellular K + and intracellular ADP, the pump is restricted to transitions between E1P and E2P, i.e. extracellular release and binding of Na + the synchronized activation of afferent SGNs by glutamate release at IHC ribbon synapses and intact propagation of spikes along the auditory pathway (Moser and Starr 2016) . Precise timing of neural activity is an important factor on which speech intelligibility and binaural hearing depend (Giraudet and Avan 2012) .
Auditory neuropathy may be an isolated feature (nonsyndromic) in some patients or part of a more widespread neuropathy or part of a syndrome disorder in others (Starr et al. 1996) . The distinction between AN and sensory (or cochlear) hearing impairment is critically important for diagnosis, prognosis and rehabilitation and there is growing evidence that AN underlies hearing dysfunction associated with several genetic and non-genetic diseases.
The combination of optic atrophy and 'sensorineural' hearing loss, coupled with known selective expression of ATP1A3 in the spiral ganglion neurons of the inner ear (McGuirt and Schulte 1994; Watts et al. 1991; Schuth et al. 2014) , indicate that the hearing loss in patients might not be due to hair cell dysfunction but to an auditory neuropathy instead. We describe 18 cases of CAPOS syndrome highlighting its unique clinical presentation, and provide evidence of an auditory neuropathy which has important implications for patient management. We model the specific mutation, p.Glu818Lys, in ATP1A3 which causes CAPOS syndrome demonstrating effects which are different to mutations associated with RDP and AHC to try and better understand the reasons for its unique clinical presentation.
Results
Clinical details of 18 patients with CAPOS syndrome are summarized in Tables 1 and 2 and in Supplementary material. Pedigrees of four familial cases and representative audiograms are shown in Figs. 2 and 3. All families showed the same recurrent heterozygous mutation in exon 18: c.2452G>A; p.Glu818Lys ( Supplementary Fig. S1 ).
Clinical histories are remarkably similar, and resemble earlier reports of CAPOS syndrome with episodes of reduced consciousness and ataxia, triggered by a febrile illness beginning suddenly in early childhood. Episodes were reminiscent of encephalitis and improved slowly over weeks or months with or without noticeable residual neurological deficit initially. Sometimes, definite but different pathogens were isolated and in case 9 three different pathogens were associated with three different episodes (raised mycoplasma titers, HPV6 infection and streptococcal throat infection). Episodes were often recurrent, and most episodes ceased in childhood but two patients experienced their last episode at or beyond 20 years of age. The single proband without episodes triggered by febrile illness (proband 18, family 11) was diagnosed with 'episodic migraine' similar to the description by Potic et al. (2015) . Children were noted to have hearing impairment and visual dysfunction that were very slowly progressive (see Supplementary material). In 3 cases, hearing impairment was diagnosed before or at the same age as the first neurological episode (cases 3, 11 and 18) but in the other 15 cases, hearing impairment was diagnosed often years after the febrile episodes (1.5-11 years) and was not apparent immediately. Nine cases had clear nystagmus which often but not always persisted following improvement of the other symptoms. Interestingly, cases 1-7 demonstrated marked variability in their pure tone audiograms, showing occasional improvement.
Audiological data are summarized in Table 2 . Six cases (cases 3, 4, 6, 16-18) had mild hearing loss, 8 had moderate (cases 1, 2, 7, 9, 10, 12, 14, 15) and four patients (cases 5, 8, 11, 13) had severe hearing loss. Hearing impairment tended to affect lower frequencies initially; it was progressive in 15 of the 18 cases (Table 2 and Fig. 3 ). In several cases, progression resulted in profound bilateral hearing loss. Some patients (cases 1, 2, 7 and 12) can only communicate with sign language (although this was not always the case) even though their pure tone audiogram shows a moderate to severe hearing loss. Their mode of communication reflects the very poor ability to understand speech even in quiet environment. Four patients (cases 9, 11, 15, 16) underwent cochlear implantation and some, particularly the children (cases 15 and 16), have gained significant benefit (See Supplementary Information, cases 15 and 16).
Hearing impairment was consistent with auditory neuropathy. Detailed audiological data are shown for case 17 in Fig. 4 . Thirteen of the 15 patients tested had OAEs; in two cases they were noted to be of particularly high amplitude (Fig. 4b, Fig. S2 ). The two cases (case 1 and case 13) without OAEs were aged 38 and 26 years and it is conceivable that OAEs had been present earlier but since disappeared as has been described for other types of auditory neuropathy. ABRs were markedly abnormal in all the 17 cases tested. Speech perception was often poor, especially in comparison with pure tone audiogram which showed only moderate or mild-moderate hearing loss in cases 15-18 (see Supplementary Information and Supplementary Figs. 5 and 6). Figure 4 illustrates data for case 17, family 10 ( Rosewich et al. 2014 ). Pure tone audiogram shows symmetric, mild to moderate hearing loss (Fig. 4a) . The discrimination of monosyllabic words in quiet was clearly impaired for conversational sound intensities (at 65 dB 50% correct discrimination at the right ear; and 60% at the left ear, but near normal at higher sound levels (80 dB: 95/100% at right/left ear). The speech recognition threshold in 65 dB background noise (Oldenburger Sentence test, binaural) was at a signal to noise ratio of + 0.5 dB (Brand and Wagener 2017) . Despite the hearing impairment 86 dB clicks readily elicited transitory evoked OAEs (TEOAE) (Fig. 4b) . Tone-evoked distortion product OAEs (DPOAEs) were present at higher amplitudes across all frequencies (Fig. 4d) indicating that the origin of the hearing impairment resides downstream of OHCs. We did not detect obvious ABRs (Fig. 4c, Supplementary Figs . S2, S3, S4, S5, S6). Transtympanic electrocochleography (Fig. 4c) , which enables direct recordings of cochlear potentials showed the presence of cochlear microphonic potentials but much reduced (Fig. 4d) . This indicates intact OHC function even in the low frequency apex of the cochlea, where the greatest hearing impairment is apparent in the pure tone audiogram.
To address the distinct effects of Glu818Lys on the α3 containing Na/K-ATPase, we expressed it with β1 in Xenopus laevis oocytes. The 818 position is located at the cytoplasmic side of transmembrane helix 6 (Fig. 5a) , where it forms a salt bridge with the backbone carbonyl of Arg930 (Fig. 5b) , a residue known to stabilize the C-terminus (Morth et al. 2017; Poulsen et al. 2010) . We, therefore, expected Glu818Lys to affect the C-terminal structure, which is critical for regulation of the Na + -specific third ion-binding site in the pump (Poulsen et al. 2010; Yaragatupalli et al. 2009; Vedovato and Gadsby 2010) . If the pump is expressed and functional, it will produce a steadystate current since one net charge is exported during each catalytic cycle, and this current will be sensitive to the pumpspecific inhibitor ouabain. With Glu818Lys, a ouabain-sensitive steady-state current is measured (data not shown). In the absence of extracellular K + , the pump will be restricted to binding and release of Na + on the extracellular side (Fig. 1) . Since the third Na + is buried in the membrane, the membrane potential can shift the distribution of occluded (E1P) and open-tothe-outside (E2P) states, and the pre-steady-state currents from binding and release of the ion can be measured to determine this distribution (Holmgren et al. 2000) . We found that with Glu818Lys, the charge translocation is markedly left-shifted (V 0.5 shifted from − 72 to − 202 mV), reflecting that the equilibrium is shifted between the sodium-binding E1P state and the open-to-the-outside E2P state towards E2P, i.e. Glu818Lys releases extracellular sodium more readily than the wild-type pump (Fig. 6) . The rate of sodium release is also accelerated compared to wild-type α3 (Fig. 6 ), though to a lesser degree than when the C-terminal structure is directly perturbed by mutagenesis (Poulsen et al. 2010) . The CAPOS mutation also causes an inward current in the absence of extracellular K + , which is not seen with the wild-type pump (Fig. 6a) . The Na, K-ATPase is known to carry an inward current of H + under certain conditions, but usually not when high Na + levels are present extracellularly (Li et al. 2006) . The pump contains a hemichannel towards the third ion-binding site which is controlled by the C-terminus. Disturbing the C-terminal structure was previously reported to cause inward currents and accelerated Na + release by opening of a hemichannel towards the third ion-binding site (Poulsen et al. 2010 ).
To test if Glu818Lys does indeed cause opening of the C-terminal structure, we performed molecular dynamic (MD) simulations from the structure of a K + -occluded pump (Shinoda et al. 2009 ). In agreement with the electrophysiological data, we found that Glu818Lys causes an opening of the C-terminal pathway that allows rapid entry of water molecules towards the ion-binding site (Fig. 7a) , but also that the effect is less pronounced than for direct mutations of the C-terminus (Fig. 7b) . Thus, the CAPOS mutation compromises pump function by destabilizing the Na + -occluded state.
Discussion
The patients presented here share remarkably similar histories-sudden episodes of neurological decline and ataxia, precipitated by febrile illness, and followed by progressive visual and hearing loss. In most cases, hearing loss was not apparent immediately, but some considerable time, often years, after the febrile episodes. It is unknown whether hearing was reduced or worsened during febrile episodes as has been reported by patients with temperature-sensitive AN related to OTOF gene mutations. (Starr et al. 1998; Zhang et al. 2016) . Our cases, together with others presenting less well-reported features, such as seizures, athetosis, choreoathetosis, dystonia, autistic features and mild learning disabilities, suggest that the phenotype partially overlaps other ATP1A3-related disorders (RDP and AHC). However, optic atrophy and hearing impairment appear confined to the CAPOS mutation (Demos et al. 2014; Rosewich et al. 2014; Heimer et al. 2015; Potic et al. 2015; Maas et al. 2016) .
We report 18 patients of whom 11 are females and 7 are males, and in all four cases with transmission to subsequent generations this occurred through a female (Fig. 2) . However among the cases in the literature, there are 11 females and 11 males (Demos et al. 2014; Rosewich et al. 2014; Heimer et al. 2015; Potic et al. 2015; Maas et al. 2016 ) and the transmission in familial cases was through females in four instances (Demos et al. 2014; Heimer et al. 2015; Potic et al. 2015) and through males in two cases (Demos et al. 2014; Potic et al. 2015) . The gender distribution and transmission to a second generation, therefore, seems to be without any particular pattern.
The location of the residue Glu818Lys suggests that it impacts the C-terminal structure, and our electrophysiological characterization and molecular dynamics simulations confirm that it has effects similar to what was previously observed when mutating the C-terminus: very low affinity for extracellular sodium and a high rate of sodium release from the third ion-binding site (Fig. 6) . However, other mutations that affect the C-terminal structure, e.g. p.Asp992Tyr, cause AHC and not CAPOS. Furthermore, a (Panagiotakaki et al. 2015; Viollet et al. 2015) . The p.Glu815Lys mutation causes a severe form of AHC with early onset, and biochemical studies suggest that it abolishes pump functionality (Weigand et al. 2014) . In CAPOS, it seems unlikely that pure loss-of-function would explain the deaf-blindness; the retinal and spiral ganglion neurons must be particularly affected by this one mutation. We, therefore, suspect that p.Glu818Lys confers a gain-of-function and/or an altered interaction with proteins specific to the ganglion neurons that future studies will be required to determine. However, the extended symptom pattern found in the 18 patients here, including the various movement disorders and psychological symptoms, which overlap with symptoms observed in RDP and AHC patients, could well be directly due to the observed impaired pumping, which will impact all α3 expressing neurons. We demonstrate that hearing impairment in patients with CAPOS is an auditory neuropathy and that the lesion lies downstream of OHC function. Indeed, the presence of OAEs in 13 of the 15 cases tested here suggests that OHC function is intact as corroborated by cochlear microphonic potentials in case 17, where electrocochleography was performed, and the observation that ABRs were pathological or absent in all CAPOS patients. In auditory neuropathy, synchronized activation of afferent SGNs by glutamate release at IHC ribbon synapses and/or propagation of spikes along the auditory pathway are impaired, resulting in poor or absent CAP and ABR and degraded speech perception and binaural hearing (Giraudet and Avan 2012; Rance and Starr 2015; Moser and Starr 2016) .
Therefore, patients with auditory neuropathy characteristically describe difficulty with hearing and understanding speech, especially in noisy environments (documented in CAPOS cases), difficulty localizing sound, and reduced music appreciation. Speech recognition and ABRs are typically more severely affected than would be expected on the The α3 subunit of the Na + /K + -ATPase encoded by the ATP1A3 gene shows highest expression in neurons; in the auditory system, it is prominently expressed in SGNs in the inner ear of several rodent species (McGuirt and Schulte 1994; Erichsen et al. 1996; McLean et al. 2009 ), both in the cell bodies and afferent terminals of myelinated nerve fibres contacting IHCs and in unmyelinated medial efferent neurons contacting OHCs (McLean et al. 2009 ). As these efferent fibres are responsible for suppression of OHC activity, the high levels of α3 may explain why OAEs in some patients with CAPOS were unusually large (cases 3, 14 and 17; Figs. S1, S4 and 4B).
Auditory neuropathy is important to diagnose because hearing rehabilitation differs from that of other types of sensorineural hearing impairment. Conventional hearing aids primarily amplify sound, and typically do not help auditory neuropathy subjects where the sound amplification by OHCs is intact (Rance and Starr 2015) ; in auditory neuropathy, it is the neural sound encoding and propagation of information which are impaired (Giraudet and Avan 2012) . Instead, cochlear implantation, which directly stimulates the neural pathways, can successfully treat some forms of auditory neuropathy depending on the site of the lesion (Harrison et al. 2015) . For example, patients with disorders of IHCs, their synapses or the myelinated dendrites of SGNs (such as those due to missense mutations in OPA1) often benefit from cochlear implantation because the site of pathology can be bypassed by electrical stimulation (Santarelli et al. 2015) . In contrast, in disorders affecting distal myelinated dendrites, SGN cell bodies, or their central axons, the outcome of cochlear implantation is variable and many patients do not benefit (Rance and Starr 2015; Giraudet and Avan 2012) . Interestingly, two of the four CAPOS patients with cochlear implants (the two youngest recipients, cases 15 and 16) have markedly benefitted as judged by improved speech recognition (see Supplementary  Information) .
Clinically, auditory neuropathy is straightforward to diagnose if the history is suggestive, and if the correct Hearing level (dB) Frequency (Hz) Fig. 3 Audiograms from cases 1, 5, 6, and 7. Case 1 shows progressive hearing loss in the right ear. Cases 5, 6, and 7 demonstrate that low frequencies are predominantly affected and that the hearing loss is symmetrical Fig. 4 Clinical data from case 17. a Audiograms at 12 years (pink/ light blue) and 14 years (red/blue) of age. b TEOAE and DPOAE with high amplitudes. c ABR to rarefaction (upper traces) and alternating (lower traces) click stimuli are absent (example left ear). A normal ABR is shown below in red with expected waveforms indicated. d Recording technique for transtympanic electrocochleography (ECochG): a needle is placed on the promontory, the bone covering the cochlea. The reference electrode (not shown) is on the contralateral mastoid. Sound stimuli are administered via a loudspeaker. e Summating potential/compound action potential complexes (arrows) to click stimulation in the patient (left ear; blue) have a very low amplitude, but the peak latency is comparable to that of a normal hearing proband (representative example in red, bottom). Right: In response to 500 Hz tone burst stimulation, cochlear microphonic potentials were present. Black lines in E indicate the time of stimulus onset. Data were acquired at age 14. Note the scale bar difference between the patient data and the example of normal ECochG recording and the difference in the shape of the click response tests are performed. Investigations may lead to the diagnosis of a known syndrome or non-syndromic auditory neuropathy, as in the case of OTOF mutations, which exert their effect at the IHC synapse, and which may be successfully helped by cochlear implantation (Rodriguez-Ballesteros et al. 2003; Rouillon et al. 2006; Santarelli et al. 2015) . In CAPOS patients, severe visual impairment due to progressive optic atrophy on top of the auditory neuropathy presents an additional challenge in establishing a satisfactory mode of communication, particularly in those who rely on vision for lip reading. For patient management and prognosis, auditory neuropathy is an important diagnosis to make.
Materials and methods

Electrophysiology
Plasmids encoding human α3 and β1 subunits of Na + /K + -ATPase were purchased from Origene (Origene, Rockville, MD, USA) and subcloned into the pXOON vector using EcoRI and NotI (Jespersen et al. 2002) . p.Glu818Lys was constructed with the quick change lightning site directed mutagenesis kit according to the manufacturer's instructions (Agilent Technologies). Constructs were sequenced to verify successful mutagenesis. α3 contains mutations p.Gln116Arg and p.Asn127Asp to reduce ouabain resistance (Price and Lingrel 1988) .
In preparation of mRNA transcription, the plasmids were linearized using NheI, purified using standard phenol/chloroform extraction, and mRNA was transcribed using the mMessage mMachine T7 Ultra Kit (Ambion, Fig. 5 Structural context of p.Glu818. a The tripartite pump is shown with the α subunit in grey, the β subunit in blue, and the γ subunit in green. The membrane is indicated with horizontal lines, the cytoplasm is below. The two occluded potassium ions are visible as red spheres in the middle of the membrane. P.Glu818 (yellow sticks) is in the transmembrane part of the pump on the cytoplasmic side, close to the C-terminus (magenta sticks). b A close-up of the structure around p.Glu818, viewed from the cytoplasmic side. The p.Glu818 carboxyl is less than 3Å from the backbone amide of Arg930, which coordinates the C-terminus. Figures made with Pymol using pdb 2ZXE Fig. 6 The CAPOS mutation affects the E1P-E2P equilibrium. a The ouabain-sensitive pre-steady-state currents of wild-type and p.Glu818Lys human Na + /K + -ATPase α3, co-expressed with β1 in Xenopus laevis oocytes, shows binding and release of extracellular sodium. b Fitting of single exponentials to pre-steady-state currents as shown in C allows the charge Q moved to be determined (top). The midpoint potential V 50 for the wild-type is − 72 ± 39 mV, and for Glu818Lys it is − 202 ± 40 mV. The rates (bottom) are also determined from the pre-steady-state currents, and the rates for the mutant are higher than for the wild-type Life Technologies, Carlsbad, CA, USA) according to manufacturer's instructions.
Oocytes from Xenopus laevis were isolated and defolliculated. 50 nl of a mixture of α3 (10 ng) and β1 (5 ng) mRNA was injected into Stage V and VI oocytes. Oocytes were incubated at 11 °C for 3-8 days prior to electrophysiological analysis.
Measurements were performed with an OC-725C voltage-clamp apparatus (Warner Instruments Corp., Hamden, CT, USA) and a Digidata 1440A (Molecular Devices, Sunnyvale, CA, USA) using the two-electrode voltageclamp technique using buffers with or without 10 mM ouabain and otherwise: 115 mM NaOH, 110 mM succinic acid, 10 mM Hepes, 5 mM BaCl 2 , 1 mM MgCl 2 , 0.5 mM CaCl 2 , 1 μM ouabain, pH 7.4. Measurements were performed in 200 ms voltage jumps in steps of 20 mV. Data were recorded with pClamp 10.4 (Molecular Devices) and analysed with Graph Pad Prism 7 (Graph Pad Software). Measurements in buffer containing 10 mM ouabain were subtracted from measurements without yielding Na + /K + -ATPase specific pre-steady-state currents, which were fitted with single exponentials to determine charge translocation and rate constants were determined by fitting single exponentials.
Molecular dynamics simulations
All-atom MD simulations were performed using a similar protocol as in our previous studies of wild-type Na + /K + -ATPase and its mutants in various conformational states (Kopec et al. 2014; Han et al. 2017; Hilbers et al. 2016) . Here, the crystal structure of Na + /K + -ATPase from shark renal gland with bound MgF 4 2− and K + (PDB ID: 2ZXE, a stable analogue of the E2*Pi*2K + state was used as a starting point of the simulations (Shinoda et al. 2009 ). The protein crystal structure, including bound potassium ions, was embedded in a fully hydrated 1-palmitoyl,2-oleoyl-snglycero-3-posphocholine (POPC). The MgF 4 2− molecule was manually deleted prior to the insertion. Glu818Lys (Glu828Lys in shark renal gland numbering) and other C-terminal point mutations (Arg940Pro and Arg1005Gln in shark renal gland numbering, and also YY-AA, where two final tyrosines of the α subunit were replaced by alanines) (Poulsen et al. 2010) were introduced with Pymol (The PyMOL Molecular Graphics System, Version 1.7.4 Schrodinger, LLC).
System construction-the K + coordinating residues: Glu334, Glu786 and Asp815 were kept protonated, as previously reported (Yu et al. 2011) . Additionally, charged residues involved in binding of the third Na + ion in E1 conformations of the pump, Asp933 and Glu961, were also protonated, as previously suggested (Poulsen et al. 2010) . The remaining glutamates and aspartates were kept in their charged forms. The Na + /K + -ATPase was embedded in an equilibrated POPC membrane (376 lipid molecules) and surrounded with ~ 63,000 water molecules. Electroneutrality was achieved by adding an adequate number of K + ions, randomly placed in the aqueous solution prior to simulations.
Patients
Details on the patients in this report were collated after the diagnosis of CAPOS was made; the genetic studies were based on clinical suspicion (apart from case 18), typically Fig. 7 MD simulations of the effect of the CAPOS mutation on the C-terminal structure. a The degree of hydration of residue p.Asp933 at the third binding site is evaluated. The radial distribution functions g(r) between p.Asp933 and water molecules shows a peak for r < 5 Å if the residue is hydrated. No peak is observed for the wild-type, but a clear peak is seen for p.Glu818Lys. Similarly, other mutations affecting the structure terminus (p.Arg940Pro, p.Arg1005Gln and YY-AA) also cause hydration of p.Asp933. b The radius of the bottleneck of the pathway was determined. In the wild-type, the radius is narrow, and the channel is closed, while p.Glu818Lys causes an opening of the channel. Other mutations directly affecting the C-terminus cause even larger openings after several years' search for a diagnosis. Clinical and audiological data have been collected retrospectively (for details see Tables 1, 2 and Supplementary Material) except for data from case 17 at age 14 which was acquired in the process of preparing the manuscript. Details are outlined in Supplementary Material.
Briefly, families 1 and 2 are unrelated and of Swedish origin; families 3, 4 and 5 are unrelated and of Danish origin; family 6 is French; families 7, 8 and 9 are from the UK, one of South Asian origin, the other two, British Caucasian; family 10 is German (reported previously but without detailed audiological data (Rosewich et al. 2014) and in family 11 the affected child has Spanish and Italian parents. Families 1, 2, 3, and 4 are two generation families (Fig. 2) ; the remainder are simplex. The patients ranged from 8 to 59 years at diagnosis.
Audiological examinations
OAE in case 17 (Fig. 4) was performed using ILOv6, Otodynamics according to manufacturer's instructions. The rejection level was 49.5 dB SPL. DPOAE stimuli were 65/55 dB and the frequency ratio was 1.22.
Calculation of pure tone averages (PTA 0,5,1,2,4 kHz ) and classification of the degree of hearing impairment followed the European recommendations (Mazzoli et al. 2003) , where 20-40 dB HL is mild; 41-70 dB Hl is moderate; 71-95 dB HL is severe; and > 95 dB Hl is profound hearing impairment.
Cochlear microphonic
Identification of cochlear microphonic potentials was achieved in cases 3, 7, 9, 11, 12, 15, 16 and 17 . In case 17 this was by electrocochleography. In the other cases, the cochlear microphonic was identified using a click ABR following recommended practice (http ://www.theb sa.org.uk/ wp-cont ent/uplo ads/2015 /02/CM).
Electrocochleography
Transtympanic electrocochleography was performed for case 17, using the Navigator pro system under sedation. The examination was done in the room adjacent to the MRI scanner (no electric or sound shielding) where other clinical data have been obtained in the same sedation which was necessary to avoid involuntary movements. A disposable monopolar needle electrode (902-DMG75-TP, Natus) was placed on the promontory and sound applied at a rate of 9.8 Hz via a custom-built 1-m long plastic tube from a TDH39 loudspeaker/P210 amplifier to avoid electric artefacts from the sound system to superimpose onto cochlear microphonic potentials based on a sound delay of 3 ms. Filtre settings were: high pass 10 Hz, low pass 5000, 50 Hz notch filtre. Electrocochleography was performed in case 12 with Interacoustics Eclipse EP equipment under general anaesthesia using insert earphones, stimuli/s 11, 3, low pass 3000 Hz, high pass none, polarity: alternating. The recording room was an ordinary hospital room, e.g. not a Faraday's cage or an audiometric booth.
Speech tests
Case 7 underwent Dantale I speech perception test (Elberling et al. 1989) . Resukts are shown in Supplementary Material.
Case 17 underwent Oldenburger sentence test (Brand and Wagener 2017) .
Case 18 underwent The Goettinger Speech Test (Chilla et al. 1976) , which measures speech understanding in children between 3-4 and 5-6 years of age. This test utilizes a list of words or picture cards that must be repeated and matched to the correct word. This test is not performed in noise.
Case 18 also underwent a test for language skills called TROG-D (test zur Überprüfe des Grammatikverständnisses) (Kampfhaus 2005) , which is a German-adapted test assessing grammatical comprehension in children aged 3-10. The test measures the understanding of 18 different sentence constructions; each sentence construction is presented four times each using different test stimuli.
Ophthalmological examination
Electrophysiological examinations were performed in accordance with principles of the International Society for Clinical Electrophysiology of Vision (Odom et al. 2016; Odom et al. 2010) . Optical coherence tomography (OCT) scanning to measure retinal nerve fibre thickness profile (RNFL) was performed using the Heidelberg Spectralis version 1.7.0.0 (Heidelberg Engineering, Heidelberg, Germany) using the inbuilt software for scanning the optic nerve head.
Sanger sequencing
ATP1A3 was sequenced by bi-directional Sanger sequencing using standard methods. Primer sequences are available on request. 
Compliance with ethical standards
Ethical approval This is a retrospective study performed in accordance with Helsinki declaration. All patients have given informed consent to publish. For case 18, the study has been approved by the Ethics Committee of the University of Würzburg (approval number: 46/15).
